GSK : Summary for GlaxoSmithKline PLC Common Stoc - Yahoo Finance

U.S. Markets closed

GlaxoSmithKline plc (GSK)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
42.41-0.28 (-0.66%)
At close: 4:02PM EDT

42.45 0.04 (0.09%)
After hours: 5:40PM EDT

People also watch
AZNNVSSNYLLYBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close42.69
Open42.61
Bid0.00 x
Ask0.00 x
Day's Range42.37 - 42.67
52 Week Range37.20 - 45.58
Volume1,911,795
Avg. Volume3,293,473
Market Cap102.28B
Beta1.04
PE Ratio (TTM)93.41
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.00 (4.74%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlaxoSmithKline Plc : GSK-US: Dividend Analysis : February 24th, 2017 (record date) : By the numbers : March 28, 2017
    Capital Cube11 hours ago

    GlaxoSmithKline Plc : GSK-US: Dividend Analysis : February 24th, 2017 (record date) : By the numbers : March 28, 2017

    Categories: Yahoo Finance Get free summary analysis Our analysis is based on comparing GlaxoSmithKline Plc with the following peers – Astrazeneca PLC Sponsored ADR, Merck & Co., Inc., Pfizer Inc., Novartis AG Sponsored ADR, Sanofi Sponsored ADR, Teva Pharmaceutical Industries Limited Sponsored ADR, Shire PLC Sponsored ADR, Dynavax Technologies Corporation and Innoviva, Inc. (AZN-US, MRK-US, PFE-US, NVS-US, SNY-US, ... Read more (Read more...)

  • Market Realist12 hours ago

    GlaxoSmithKline’s Segment-Wise Performance in 2016

    GSK's Consumer Health revenues increased ~9% during 2016 to ~7.2 billion pounds. The increase was mainly due to the Wellness and Skin Health franchise.

  • Market Realist13 hours ago

    Performance of GlaxoSmithKline in 2016

    GlaxoSmithKline’s top line increased 17% to ~27.9 billion pounds for 2016, driven by an operational increase of 6% and a favorable currency impact of ~11%.